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Chromosomal Aberrations and Bone
Marrow Toxicity
by John A. Heddle* and Michael F. Salamone*
The importance ofchromosomal aberrations as a proximate cause ofbone marrow toxicity is
discussed. Since chemicals that can cause nondisjunction are rare, numerical aberrations
(aneuploidy, polyploidy) are not ordinarily important. Many structural aberrations, however,
can lead directly to cell death and so are proximate causes of toxicity when they occur. The
micronucleus test which utilizes the polychromatic erythrocyte is capable of detecting agents
(clastogens) that can cause such structural aberrations. Many carcinogens can be detected by
this test, and recent changes in the protocol may increase the success rate. Nevertheless only a
small proportion ofchemicals are clastogens. The importance ofcell division in the expression
ofchromosomal damage and the stage ofthe cell cycle at the time ofexposure on the amount of
damage is emphasized.
A speculative mechanism for the relationship between chromosomal aberrations and
carcinogenicity is proposed.
There are two broad classes of chromosomal
aberrations: numerical aberrations in which whole
chromosomes areeitherlostoradded, (e.g. trisomy-21
or Down's syndrome) and structural aberrations in
which pieces of chromosome are lost, added, or
translocated, for example the Philadelphia chromo-
some which leads to chronic myeloid leukemia.
Obviously either class of aberration, if inherited,
can have a significant influence on human health.
These aberrations arise in fundamentally different
ways. Aneuploidy, i.e., numerical aberrations in-
volving other than a full complement of chromo-
somes, arise as a result ofnondisjunction which is a
failure ofthe proper distribution ofchromosomes to
daughter cells. Agents that interact directly with
the cell's spindle mechanism are able to cause
nondisjunction; there are also scattered reports
which suggest that other agents may also be able to
cause nondisjunction, perhaps by some indirect
mechanism. Similarly, inhibition of the cell's spin-
dle formation can lead to polyploidy, i.e., the gain
or loss of whole haploid sets of chromosomes. In
most tissues polyploid and aneuploid cells are rare
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after treatment by toxic agents, even those agents
capable of causing structural chromosomal aberra-
tions. Thus such aberrations are not usually impor-
tant contributors to the toxic response. Vincristine
and vinblastine are probably exceptions to this, but
their irreversible binding to microtubules may
cause toxicity by other means as well.
Structural aberrations, in contrast, can lead
directly to cell death and are often major contribu-
tors to toxicity. With respect to toxicity, the kinds
of chromosomal aberrations (which from this point
on in this paper means structural abnormalities
exceptwhere otherwise indicated) may be classified
in two ways: those that lead to the loss of genetic
information at cell division and those that do not.
This is shown diagrammatically in Figure 1. Those
aberrations (of which only one of many possible
types is shown) that involve a rearrangement of
gene order rather than a direct loss of a gene are
not cell lethal events and, hence, are not contribu-
tors to cellular toxicity. In contrast, those aberra-
tions that lead directly to the loss of a section of
genetic information are usually cell lethal events
and do contribute directly to cellular toxicity.
These aberrations may involve an acentric chromo-
somal fragment whose movement at anaphase is
dependent upon cytoplasmic currents so that the
23fragment may or may not be swept into a position
from which it can be incorporated into a daughter
nucleus. If the fragment is not incorporated into
one ofthe daughter nuclei it will become a micronu-
cleus, a small body that resembles a normal nucleus
except for its size and possibly the presence of
nucleoli (see Fig. 2). Ifthe fragment is incorporated
into a daughter nucleus it will be replicated so that
a double fragment is present at the next cell
division. If the fragment was already double there
will be two fragments present, either or both of
which may be lost to become micronuclei. Thus the
longer a fragment escapes anaphase loss and mi-
cronucleusformation, themorepotentialmicronuclei
exist.
The actual mechanism by which the loss of a
chromosomal fragment causes death in adiploid cell
is not known. It may be that recessive lethal genes
existing on the homolog are made hemizygous by
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the loss of the fragment. Alternatively, it may be
that the genetic imbalance between those loci
represented twice and those loci represented only
once (as aresult ofthe fragment loss) is lethal. Both
mechanisms are undoubtedly involved to some
extent,withtheirrelativeimportancebeinginfluenced
by the actual chromosomal region involved and the
demands placed upon the genome by the stage of
cell differentiation involved.
Regardless ofthe mechanism by which the loss of
a chromosomal region causes cell death, the loss
itself is dependent upon cell division. According to
this idea the induction of chromosomal aberrations
should not affect cells that do not divide orhave not
yet divided. Traditional techniques do not permit a
direct test of this idea because the aberrations
cannot be detected unless the cells divide. Indirect
lines of evidence rather strongly favor this view-
point, however. For example, numerous tests of
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FIGURE 1. (A) Schematic diagram ofa chromatid deletion and its fate (1) at metaphase, (2) at anaphase, (3)
at telophase, and (4) the resultant micronucleus at interphase. The genetic information contained in the
micronucleus is ordinarily unavailable to the cell which may be either the daughter cell with the deletion
or the daughter cell with the normal chromosomal complement. (B) A chromatid translocation
(asymmetrical chromatid interchange) at metaphase which may segregate either (1) in a balanced form,
or (2) in an unbalanced form giving a duplication for one region and a deficiency for the other in each
daughter cell. (C) A chromatid inversion (asymmetrical chromatid intrachange) (1) at metaphase and (2)
at anaphase. This aberration will not ordinarly be lethal or have any other genetic consequence in a
somatic cell.
Environmental Health Perspectives 24FIGURE 2. Bone marrow preparation showing micronuclei (Howell-Jolley bodies) in two polychromatic
erythrocytes and a mature erythrocyte (central cell of the three cells).
the importance ofaberrations showthat, at doses of
ionizing radiation which 10% or more of the cells
can survive, the majority of cell death in dividing
cellular populations is attributable to chromosomal
aberrations. At these doses virtually no cell death
is observed in nondividing cell populations. How-
ever, if such populations, for example liver, are
stimulated to divide, then a wave ofcell death and
necrosis occurs. Furthermore, aberrations that
involve rearrangement without loss of genomic
material are often not cell lethal but are maintained
through many cell divisions. Although this view is
probably broadly correct, new techniques of cell
fusion enable one to examine chromosomes in
nondividing cells for aberrations and have thereby
revealed at least some cells more heavily damaged
than those seen at division (1). It may be, there-
fore, that there is a reduced division potential in
heavily damaged cells even before the first division.
It remains true, however, that the tissues sensitive
to ionizing radiation and to chemicals that can cause
chromosomal damage are normally those undergo-
ing rapid proliferation.
In the case of ionizing radiation, the cells are
sensitive to chromosomal damage at all stages of
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the cell cycle (2). With chemicals the situation is
more complex. Although DNA damage may be
induced at any stage of the cell cycle, the aberra-
tions are often produced only during S. Thus cells
treated with nitrogen mustard in G2 appear normal
at the first division after treatment but may be
heavily laden with chromosomal aberrations at the
second division (3). Cells ofnondividing tissues are
normally found in the G1 phase. Provided that such
cells are not stimulated to enter S and divide for
some time after treatment, much of the DNA
damage may be repaired prior to S and thus much
chromosomal damage may be avoided. Possibly this
is true for stem cells in the bone marrow while the
proliferating compartment suffers extensive dam-
age.
Because it is a ready source ofdividing cells, the
bone marrow has been a favorite tissue for studies
of chromosomal aberrations in vivo. Traditional
chromosomal analysis has suffered, however, from
being a time-consuming process and from being a
rather specialized field in which many of the basic
concepts arose in nonmammalian systems. As a
consequence, many ofthe in vivo experiments have
beeninadequate in the numberofcells sampled, the
25time of sampling, or both. In addition, inadequate
dose levels have often been used. There is a natural
reluctance to work at levels too close to lethal levels
for fear of nonspecific effects. Unfortunately al-
though aberrations probably occur even at very low
doses, too much scoring effort is required at such
low doses, especially as a noticeable spontaneous
rate does exist. Once aberrations are common
enough to detect easily, cell death is the conse-
quence and thus the animal's life is endangered.
Therefore it is inevitable that aberrations will be
easily detected only at doses close to the LD50. This
does not mean that aberrations are a nonspecific
consequence of toxicity nor that they do not occur
at lower doses. Rather the association between
significant frequencies ofaberrations and toxicity is
aconsequence ofthestatisticalproblems ofdetecting
low levels together with the importance of high
aberration frequencies causing toxicity and death.
Nonspecific induction of chromosomal aberrations
has never been established as a real mechanism.
Cytogeneticists interested in the mechanisms by
which chromosomal aberrations arise place great
store on details of the types and kinds of aberra-
tions produced. The classifications are relatively
complicated and are not of concern here except to
say that they depend upon analysis at metaphase.
The question of whether or not an agent can cause
chromosomal breakage can be answered much more
simply. As outlined earlier, acentric chromosomal
fragments become micronuclei when lost during cell
division. While these micronuclei do not provide the
cytogeneticist with important details ofthe aberra-
tion types from which they arose, they are much
more easily and rapidly quantified and so provide a
simple means of detecting the occurrence of chro-
mosomal damage. No agents have yet been found
that can cause aberrations of any kind without
causing those kinds that have associated acentric
fragments. Micronuclei should thus be a reliable
index of chromosome damage. Micronuclei were
used once as an experimental tool in plants and
noted occasionally in other circumstances but were
not used as an assay until independently proposed
by Schmid and co-workers (4) and Heddle (5). The
cell type proposed by Schmid was the polychro-
matic erythrocyte (see Fig. 2). This cell, although
not itself a dividing cell is the immediate product of
a series of cell divisions. The success of this assay
can be judged by the fact that it has largely
replaced traditional metaphase analysis in the screen-
ing ofchemicals for their ability to produce chromo-
somal damage in vivo. More than 200 chemicals
have now been tested, about a third of which were
found positive. Of course the selection of agents
was highly non-random and included a high propor-
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tion of known mutagens and carcinogens. Recent
advances suggest that a success rate greater than
50% in detecting carcinogens can be expected with
few if any false positives (6).
Since micronuclei arise as a consequence of
chromosomal loss during cell division, there is
inevitably some lag period before they begin to
appear. In human lymphocytes in vitro this lag is
approximately 40 hr because few divisions occur
before this (7). The maximum frequency occurs
after about three cell divisions in the lymphocyte
cultures, but this will depend upon the frequency of
fragment loss per cell division. In lymphocyte
cultures this has been estimated to be 20% per cell
division (8). In systems in which fragment loss is
more frequent the maximum should occur earlier.
In the polychromatic erythrocyte (PCE) cell assay
there is an additional factor: the time between the
last division and the expulsion of the main nucleus
(9). As a consequence of this, no micronuclei are
detectable in PCE for at least 8-10 hr after treat-
ment. Treatments given within this interval are
wasted and may even be harmful by depressing
PCE production or causing artefacts. Until recently
this has not been taken into account so that the
majority of testing has occurred under less than
optimal conditions.
A second factor of importance in this assay, but
not recognized until recently, has been the time
course of micronucleus production. Although some
mutagens such as x-rays or mitomycin C result in a
maximum production soon after treatment, i.e., at
about 36 hr, others show maximum frequencies at
later times. Dimethylbenzanthracene, for example,
gives a maximum at about 72 hr that is more than
five times the frequency at 36 hr (Fig. 3). The
reason for this variation in the time of maximum
response is not clear; we have speculated that it is
related to the uptake and metabolism of the agent
rather than any fundamental difference in the
interaction with the bone marrow (6). The problem
raised by this finding is that some agents may not
produce detectable increases at 36 hr but are
detectable at 72 hr. Indeed a new protocol devised
to take account of this possibility led to three
carcinogens that were not detectable at early times
being detected at later times (6). Because the
results even at late times were marginal, this result
needs to be confirmed. At the moment, however, it
seems likely that the addition of later sampling
times to the standard protocol will increase the
proportion of carcinogens detected by this assay.
The micronucleus assay seems at the moment to
be a robust assay with a moderate success rate. It
is robust in that few laboratory to laboratory
discrepancies have emerged. The success rate has
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FIGURE 3. Time course of micronucleus production for three
agents: (0) mitomycin C; (A\) cyclophosphamide; (LI)
9,10-dimethylbenzanthracene. In each case the proportion of
the total number of micronuclei observed is shown as a
function of time.
usually been in the 40% to 60% range. Since the
protocols have almost always been less than opti-
mal, it is likely that the time success rate will be
higher. Nevertheless, it is unlikely that any tissue-
specific assay will be 100% successful, and this assay
measures only one class of genetic damage. In our
opinion, and we must stress that it is only an
opinion, the assay detects quite a high fraction of
the most potent human carcinogens. We believe
that this is true not because the aberrations them-
selves are the cause of cancer (and certainly not
those that lead to micronuclei) but because the cell
death that these aberrations cause leads to in-
creased cellular proliferation and hence to an in-
creased likelihood that a quiescent but transformed
cell will be called upon to divide. Once called upon
to divide it is able to express its cancerous pheno-
type, i.e., it does not respond adequately to the
normal feedback mechanisms that keep cell produc-
tion in balance with cell loss.
To return from the issue ofgenetic toxicology to
bone marrow toxicity, it should be evident from
this discussion that genotoxic agents can contribute
greatly to toxicity in any dividing cell population.
In the bone marrow in which there are so many
different proliferating cell populations, large doses
of such chemicals can be expected to produce a
pancytopenia; at lower doses some populations may
be more or less severely affected than others.
Certainly the time course of toxicity arising in
sub-populations will differ according to their rate of
proliferation and to the fraction of cells in the
sensitive phases of the cell cycle, as well as to the
dose they receive. Genetic toxicity is to be expected
from a relatively small minority ofchemicals, a few
per cent of chemicals at most. The rapid advances
in genetic testing are making the detection of such
chemicals a much more reliable process. It will be
interesting to see if diseases other than cancer,
birth defects, and genetic abnormalities will be
foundtobeassociatedwithgenotoxicity andwhether
specific genetic events can be shown to be the cause
of somatic diseases such as leukemia.
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